STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 90 filers reported holding STEMLINE THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 11.73 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $4,834,000 | -54.5% | 998,677 | 0.0% | 0.07% | -47.2% |
| Q4 2019 | $10,616,000 | +2.1% | 998,677 | 0.0% | 0.13% | -3.8% |
| Q3 2019 | $10,396,000 | -20.9% | 998,677 | +16.4% | 0.13% | -19.0% |
| Q2 2019 | $13,146,000 | +185.7% | 858,082 | +139.6% | 0.16% | +181.0% |
| Q1 2019 | $4,601,000 | +265.7% | 358,082 | +170.4% | 0.06% | +222.2% |
| Q4 2018 | $1,258,000 | -57.8% | 132,428 | -26.2% | 0.02% | -52.6% |
| Q3 2018 | $2,978,000 | -13.2% | 179,409 | -16.0% | 0.04% | -20.8% |
| Q2 2018 | $3,430,000 | +31.9% | 213,706 | +25.7% | 0.05% | +20.0% |
| Q1 2018 | $2,601,000 | -14.7% | 169,995 | -13.0% | 0.04% | -9.1% |
| Q4 2017 | $3,049,000 | +71.7% | 195,437 | +22.1% | 0.04% | +76.0% |
| Q3 2017 | $1,776,000 | +387.9% | 160,000 | +649.4% | 0.02% | +400.0% |
| Q4 2014 | $364,000 | +37.4% | 21,350 | 0.0% | 0.01% | +25.0% |
| Q3 2014 | $265,000 | – | 21,350 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management II, LLC | 315,980 | $3,381,000 | 1.62% |
| VHCP Management, LLC | 135,420 | $1,449,000 | 1.56% |
| Eventide Asset Management | 851,400 | $9,110,000 | 0.59% |
| CARL DOMINO INC | 26,000 | $278,000 | 0.30% |
| SABBY MANAGEMENT, LLC | 357,806 | $3,829,000 | 0.22% |
| Telemetry Investments, L.L.C. | 25,016 | $268,000 | 0.15% |
| J. Goldman & Co LP | 199,886 | $2,139,000 | 0.14% |
| BAILARD, INC. | 123,785 | $1,324,000 | 0.12% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 94,945 | $1,015,000 | 0.07% |
| Candriam S.C.A. | 244,000 | $2,611,000 | 0.06% |